NONPRESCRIPTION DRUG PROMOTION IN MASS-MEDIA PRINT PUBLICATION IN INDONESIA

The objectives of the study were to identify whether nonprescription drug promotion in mass-media print publications in Indonesia complied with the regulations of “Keputusan Menteri Kesehatan No. 386/Men.Kes/SK/IV/1994” on drug promotion and WHO Ethical Criteria for Medicinal Drug Promotion, as well...

Full description

Bibliographic Details
Main Author: FITA RAHMAWATI
Format: Article
Language:English
Published: Universiti Sains Malaysia 2007-01-01
Series:Malaysian Journal of Pharmaceutical Sciences
Subjects:
Online Access:http://www.usm.my/mjps/MJPS%205%20(1)%202007/MJPS%205.1.1.pdf
id doaj-81e095b15fd34ed29324b6284577a439
record_format Article
spelling doaj-81e095b15fd34ed29324b6284577a4392020-11-24T23:19:56ZengUniversiti Sains MalaysiaMalaysian Journal of Pharmaceutical Sciences1675-73191985-83962007-01-015116NONPRESCRIPTION DRUG PROMOTION IN MASS-MEDIA PRINT PUBLICATION IN INDONESIAFITA RAHMAWATIThe objectives of the study were to identify whether nonprescription drug promotion in mass-media print publications in Indonesia complied with the regulations of “Keputusan Menteri Kesehatan No. 386/Men.Kes/SK/IV/1994” on drug promotion and WHO Ethical Criteria for Medicinal Drug Promotion, as well as to identify the type of information given to consumers. The study was conducted by random sampling of 110 advertisements from mass-media print publications from the year 2000 until 2004. The results of the study showed that only 1.8% of nonprescription drug advertisements complied with the regulations. The type of information advertised to consumers was the active ingredient(s) (80.9%), major indications for use (98.2%), major precautions (9.1%), contra-indications (5.4%), side effects (20.9%), the name of the product or the brand name (100%), name of manufacturer or distributor (93.6%), address of manufacturer/distributor (45.5%), dosage (80.9%), and registration number (82.7%). Our findings showed that 27.3% advertisements did not list the active ingredient(s) completely or used no International Nonproprietary Name (INN), and 44.5% advertisements contained claims of product effectiveness that were unsupported by clinical or other scientific evidence.http://www.usm.my/mjps/MJPS%205%20(1)%202007/MJPS%205.1.1.pdfNonprescription medicineDrug promotionAdvertisements
collection DOAJ
language English
format Article
sources DOAJ
author FITA RAHMAWATI
spellingShingle FITA RAHMAWATI
NONPRESCRIPTION DRUG PROMOTION IN MASS-MEDIA PRINT PUBLICATION IN INDONESIA
Malaysian Journal of Pharmaceutical Sciences
Nonprescription medicine
Drug promotion
Advertisements
author_facet FITA RAHMAWATI
author_sort FITA RAHMAWATI
title NONPRESCRIPTION DRUG PROMOTION IN MASS-MEDIA PRINT PUBLICATION IN INDONESIA
title_short NONPRESCRIPTION DRUG PROMOTION IN MASS-MEDIA PRINT PUBLICATION IN INDONESIA
title_full NONPRESCRIPTION DRUG PROMOTION IN MASS-MEDIA PRINT PUBLICATION IN INDONESIA
title_fullStr NONPRESCRIPTION DRUG PROMOTION IN MASS-MEDIA PRINT PUBLICATION IN INDONESIA
title_full_unstemmed NONPRESCRIPTION DRUG PROMOTION IN MASS-MEDIA PRINT PUBLICATION IN INDONESIA
title_sort nonprescription drug promotion in mass-media print publication in indonesia
publisher Universiti Sains Malaysia
series Malaysian Journal of Pharmaceutical Sciences
issn 1675-7319
1985-8396
publishDate 2007-01-01
description The objectives of the study were to identify whether nonprescription drug promotion in mass-media print publications in Indonesia complied with the regulations of “Keputusan Menteri Kesehatan No. 386/Men.Kes/SK/IV/1994” on drug promotion and WHO Ethical Criteria for Medicinal Drug Promotion, as well as to identify the type of information given to consumers. The study was conducted by random sampling of 110 advertisements from mass-media print publications from the year 2000 until 2004. The results of the study showed that only 1.8% of nonprescription drug advertisements complied with the regulations. The type of information advertised to consumers was the active ingredient(s) (80.9%), major indications for use (98.2%), major precautions (9.1%), contra-indications (5.4%), side effects (20.9%), the name of the product or the brand name (100%), name of manufacturer or distributor (93.6%), address of manufacturer/distributor (45.5%), dosage (80.9%), and registration number (82.7%). Our findings showed that 27.3% advertisements did not list the active ingredient(s) completely or used no International Nonproprietary Name (INN), and 44.5% advertisements contained claims of product effectiveness that were unsupported by clinical or other scientific evidence.
topic Nonprescription medicine
Drug promotion
Advertisements
url http://www.usm.my/mjps/MJPS%205%20(1)%202007/MJPS%205.1.1.pdf
work_keys_str_mv AT fitarahmawati nonprescriptiondrugpromotioninmassmediaprintpublicationinindonesia
_version_ 1725576152117936128